Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lawrie

Showing results (591-600 of 638) with videos related to

Pageof 64
Sort By:
Schizophrenia Research. Cognition|April 4, 2024
PsyCog: A computerised mini battery for assessing cognition in psychosisGeorge Gifford, Alexis E Cullen, Sandra Vieira, et al.
Plos One|March 26, 2013
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adultsCaroline Ogwang, Muhammed Afolabi, Domtila Kimani, et al.
NPJ Vaccines|August 23, 2018
Production, quality control, stability, and potency of cGMP-produced <i>Plasmodium falciparum</i> RH5.1 protein vaccine expressed in <i>Drosophila</i> S2 cellsJing Jin, Richard D Tarrant, Emma J Bolam, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2026
Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stagesPaolo Fusar-Poli, Toby Pillinger, Robert A McCutcheon, et al.
Translational Psychiatry|September 8, 2018
DISC1 regulates N-methyl-D-aspartate receptor dynamics: abnormalities induced by a Disc1 mutation modelling a translocation linked to major mental illnessElise L V Malavasi, Kyriakos D Economides, Ellen Grünewald, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2014
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populationsDomtila Kimani, Ya Jankey Jagne, Momodou Cox, et al.
Med (New York, N.Y.)|August 12, 2023
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adultsSarah E Silk, Wilmina F Kalinga, Ivanny M Mtaka, et al.
The American Journal of Psychiatry|March 28, 2020
The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA ConsortiumLaurena Holleran, Sinead Kelly, Clara Alloza, et al.
Science Translational Medicine|July 12, 2023
Vaccination with <i>Plasmodium vivax</i> Duffy-binding protein inhibits parasite growth during controlled human malaria infectionMimi M Hou, Jordan R Barrett, Yrene Themistocleous, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
Impact of a blood-stage vaccine on <i>Plasmodium vivax</i> malariaMimi M Hou, Jordan R Barrett, Yrene Themistocleous, et al.
Pageof 64

Showing results (591-600 of 638) with videos related to

Sort By:
Pageof 64
Schizophrenia Research. Cognition|April 4, 2024
PsyCog: A computerised mini battery for assessing cognition in psychosisGeorge Gifford, Alexis E Cullen, Sandra Vieira, et al.
Plos One|March 26, 2013
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adultsCaroline Ogwang, Muhammed Afolabi, Domtila Kimani, et al.
NPJ Vaccines|August 23, 2018
Production, quality control, stability, and potency of cGMP-produced <i>Plasmodium falciparum</i> RH5.1 protein vaccine expressed in <i>Drosophila</i> S2 cellsJing Jin, Richard D Tarrant, Emma J Bolam, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2026
Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stagesPaolo Fusar-Poli, Toby Pillinger, Robert A McCutcheon, et al.
Translational Psychiatry|September 8, 2018
DISC1 regulates N-methyl-D-aspartate receptor dynamics: abnormalities induced by a Disc1 mutation modelling a translocation linked to major mental illnessElise L V Malavasi, Kyriakos D Economides, Ellen Grünewald, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2014
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populationsDomtila Kimani, Ya Jankey Jagne, Momodou Cox, et al.
Med (New York, N.Y.)|August 12, 2023
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adultsSarah E Silk, Wilmina F Kalinga, Ivanny M Mtaka, et al.
The American Journal of Psychiatry|March 28, 2020
The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA ConsortiumLaurena Holleran, Sinead Kelly, Clara Alloza, et al.
Science Translational Medicine|July 12, 2023
Vaccination with <i>Plasmodium vivax</i> Duffy-binding protein inhibits parasite growth during controlled human malaria infectionMimi M Hou, Jordan R Barrett, Yrene Themistocleous, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2022
Impact of a blood-stage vaccine on <i>Plasmodium vivax</i> malariaMimi M Hou, Jordan R Barrett, Yrene Themistocleous, et al.
Pageof 64